title: Lot-release criteria, postlicensure quality control, and the Haemophilus influenzae type b conjugate vaccines.
authors.forename: W
authors.initials: W
authors.lastname: Egan
authors.forename: C E
authors.initials: CE
authors.lastname: Frasch
authors.forename: B F
authors.initials: BF
authors.lastname: Anthony
mesh_terms: D016667:Bacterial Capsules; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology / Q000592:standards*; D001426:Bacterial Proteins / Q000276:immunology / Q000592:standards*; D004345:Drug Industry / Q000592:standards*; D018073:Haemophilus Vaccines / Q000276:immunology / Q000592:standards*; D006801:Humans; D011135:Polysaccharides, Bacterial / Q000276:immunology; D011786:Quality Control; D018074:Vaccines, Conjugate / Q000276:immunology / Q000592:standards*; D014614:Vaccines, Synthetic / Q000276:immunology / Q000592:standards*
chemical_list: D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; C061964:Haemophilus influenzae-type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine; D011135:Polysaccharides, Bacterial; D018074:Vaccines, Conjugate; D014614:Vaccines, Synthetic; C061963:HibTITER protein, Haemophilus influenzae